Net Margin - BioNote Inc (KRX:377740) - Alpha Spread
B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 595 KRW 0.33% Market Closed
Market Cap: 468.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

Net Margin
BioNote Inc

20.4%
Current
3%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.4%
=
Net Income
19.2B
/
Revenue
94.2B

Net Margin Across Competitors

Country KR
Market Cap 468.9B KRW
Net Margin
20%
Country US
Market Cap 341.9B USD
Net Margin
10%
Country US
Market Cap 180.5B USD
Net Margin
10%
Country US
Market Cap 127.8B USD
Net Margin
32%
Country US
Market Cap 123.3B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country US
Market Cap 104.5B USD
Net Margin
4%
Country AU
Market Cap 141.9B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.5B USD
Net Margin
-557%
Country US
Market Cap 35.4B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for BioNote Inc.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
20.4%
=
Net Income
19.2B
/
Revenue
94.2B
What is the Net Margin of BioNote Inc?

Based on BioNote Inc's most recent financial statements, the company has Net Margin of 20.4%.